Volkan Hazar, Vural Kesik, Serap Aksoylar, Musa Karakukcu, Gulyuz Ozturk, Alphan Kupesiz, Erman Atas, Haldun Oniz, Savas Kansoy, Ekrem Unal, Atila Tanyeli, Fatih Erbey, Murat Elli, Nurdan Tacyildiz, Gulsun Tezcan Karasu, Ulker Kocak, Sema Anak, Sebnem Yilmaz Bengoa, Gulay Sezgin, Didem Atay, Emel Unal, Vedat Uygun, Nilgun Kurucu, Zuhre Kaya, Akif Yesilipek
This study evaluates the outcome of 66 pediatric patients with rrHL who underwent autoHSCT. Twenty-nine patients experienced early relapse, and 19 patients experienced late relapse. Of 18 newly diagnosed with HL, 13 were primary refractory disease and five had late responsive disease. At the time of transplantation, only 68% of the patients were chemosensitive. The majority of patients received BCNU + etoposide + ara-C + melphalan for conditioning (45/66), and peripheral blood (56/66) was used as a source of stem cells...
November 2015: Pediatric Transplantation